JP7153668B2 - 自動基礎インスリン制御及び手動ボーラスインスリン制御を有する糖尿病管理システム - Google Patents
自動基礎インスリン制御及び手動ボーラスインスリン制御を有する糖尿病管理システム Download PDFInfo
- Publication number
- JP7153668B2 JP7153668B2 JP2019556661A JP2019556661A JP7153668B2 JP 7153668 B2 JP7153668 B2 JP 7153668B2 JP 2019556661 A JP2019556661 A JP 2019556661A JP 2019556661 A JP2019556661 A JP 2019556661A JP 7153668 B2 JP7153668 B2 JP 7153668B2
- Authority
- JP
- Japan
- Prior art keywords
- subject
- insulin
- management system
- insulin dose
- blood glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
- A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
- A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
- A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Medical Informatics (AREA)
- Diabetes (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Emergency Medicine (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
Description
次に、具体的な実施例を挙げて説明する。患者は、1単位のインスリン感受性因子(「ISF」)50mg/dL、目標血糖値100mg/dL、及びMPCコントローラのグルコース制御範囲90~180mg/dLを有してよい。
提案された補正=0u
Claims (13)
- 糖尿病管理システムであって、
被験者にインスリンを送達するための送達装置と、
前記被験者の血糖値を測定するためのグルコースセンサと、
コントローラであって、
前記グルコースセンサから前記被験者の血糖値を定期的に受信し、
モデル予測制御アルゴリズム、並びに前記被験者の、所望の血糖値、送達されたインスリンの量、及び測定された血糖値を含む前記被験者の生理学的データを使用して、基礎インスリン投与量を自動的に計算し、
前記被験者によって開始された手動ボーラスインスリン投与量を受信し、
前記生理学的データに基づいて前記被験者の近い将来の低血糖変動があるかどうか、前記モデル予測制御アルゴリズムを使用して、予測し、
予測された近い将来の低血糖変動に基づいて、前記手動ボーラスインスリン投与量を修正し、
前記修正された手動ボーラスインスリン投与量及び前記計算された基礎インスリン投与量に基づいて総インスリン投与量を決定し、
前記総インスリン投与量を前記被験者に送達するように構成されている、コントローラと、を備える、糖尿病管理システム。 - 前記手動ボーラスインスリン投与量は、前記被験者の現在の血糖値と前記被験者の目標血糖値との差、前記被験者のグルコース感受性、及び前記被験者のオンボードインスリンレベルに応じて計算される、請求項1に記載の糖尿病管理システム。
- 前記修正は、予測された前記近い将来の低血糖変動に基づいて、前記手動ボーラスインスリン投与量を減少することを含む、請求項1に記載の糖尿病管理システム。
- 前記修正することは、前記手動ボーラスインスリン投与量を相殺することを含む、請求項1に記載の糖尿病管理システム。
- 前記糖尿病管理システムはボーラス計算機を更に含み、前記コントローラは、前記ボーラス計算機から前記手動ボーラスインスリン投与量を受信する、請求項1に記載の糖尿病管理システム。
- 前記ボーラス計算機は前記手動ボーラスインスリン投与量を計算して、現在の血糖値と目標血糖値との差、前記被験者のグルコース感受性、及び前記被験者のインスリンのオンボードレベルに応じて目標血糖値を達成する、請求項5に記載の糖尿病管理システム。
- 自動基礎インスリン制御及び手動ボーラスインスリン制御を有する糖尿病管理システムであって、前記糖尿病管理システムは、
被験者にインスリンを送達するための送達装置と、
前記被験者の血糖値を測定するためのグルコースセンサと、
コントローラであって、
前記グルコースセンサから前記被験者の血糖値を受信し、
モデル予測制御アルゴリズム、並びに前記被験者の所望の血糖値、送達されたインスリンの量、及び測定された血糖値など前記被験者の生理学的データを使用して、基礎インスリン投与量を自動的に計算し、
前記被験者によって開始された手動ボーラスインスリン投与量を受信し、
前記生理学的データに基づいて前記被験者の近い将来の低血糖変動があるかどうか、モデル予測制御アルゴリズムを使用して、予測し、
低血糖を示す近い将来の低血糖変動があると予測される場合は、前記手動ボーラスインスリン投与量を修正するように構成されている、
コントローラと、を備える、糖尿病管理システム。 - 前記コントローラは、前記修正された手動ボーラスインスリン投与量及び前記計算された基礎インスリン投与量に基づいて総インスリン投与量を決定するように更に構成されている、請求項7に記載の糖尿病管理システム。
- 前記コントローラは、前記被験者に前記総インスリン投与量を送達するよう前記送達装置に命令するように更に構成されている、請求項7に記載の糖尿病管理システム。
- 前記手動ボーラスインスリン投与量は、前記被験者の現在の血糖値と前記被験者の目標血糖値との差、前記被験者のグルコース感受性、及び前記被験者のオンボードインスリンレベルに応じて計算される、請求項7に記載の糖尿病管理システム。
- 前記修正は、予測された前記近い将来の低血糖変動に基づいて、前記手動ボーラスインスリン投与量を減少することを含む、請求項7に記載の糖尿病管理システム。
- 前記修正することは、前記手動ボーラスインスリン投与量を相殺することを含む、請求項7に記載の糖尿病管理システム。
- 前記糖尿病管理システムはボーラス計算機を更に含み、前記コントローラは、前記ボーラス計算機から前記手動ボーラスインスリン投与量を受信する、請求項7に記載の糖尿病管理システム。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/489,773 US11147920B2 (en) | 2017-04-18 | 2017-04-18 | Diabetes management system with automatic basal and manual bolus insulin control |
US15/489,773 | 2017-04-18 | ||
PCT/US2018/026208 WO2018194838A1 (en) | 2017-04-18 | 2018-04-05 | Diabetes management system with automatic basal and manual bolus insulin control |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020518327A JP2020518327A (ja) | 2020-06-25 |
JP7153668B2 true JP7153668B2 (ja) | 2022-10-14 |
Family
ID=63791872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019556661A Active JP7153668B2 (ja) | 2017-04-18 | 2018-04-05 | 自動基礎インスリン制御及び手動ボーラスインスリン制御を有する糖尿病管理システム |
Country Status (11)
Country | Link |
---|---|
US (2) | US11147920B2 (ja) |
EP (1) | EP3612255A4 (ja) |
JP (1) | JP7153668B2 (ja) |
KR (1) | KR20190141704A (ja) |
CN (1) | CN110913930B (ja) |
AU (1) | AU2018255170A1 (ja) |
BR (1) | BR112019021802A2 (ja) |
CA (1) | CA3062078A1 (ja) |
RU (1) | RU2758210C2 (ja) |
TW (1) | TW201900229A (ja) |
WO (1) | WO2018194838A1 (ja) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1762259B1 (en) | 2005-09-12 | 2010-09-08 | Unomedical A/S | Inserter for an infusion set with a first and second spring units |
US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
WO2012123274A1 (en) | 2011-03-14 | 2012-09-20 | Unomedical A/S | Inserter system with transport protection |
GB2523989B (en) | 2014-01-30 | 2020-07-29 | Insulet Netherlands B V | Therapeutic product delivery system and method of pairing |
US10441717B2 (en) | 2014-04-15 | 2019-10-15 | Insulet Corporation | Monitoring a physiological parameter associated with tissue of a host to confirm delivery of medication |
AU2016219961B2 (en) | 2015-02-18 | 2020-07-02 | Insulet Corporation | Fluid delivery and infusion devices, and methods of use thereof |
WO2017027459A1 (en) | 2015-08-07 | 2017-02-16 | Trustees Of Boston University | Glucose control system with automatic adaptation of glucose target |
WO2017123525A1 (en) | 2016-01-13 | 2017-07-20 | Bigfoot Biomedical, Inc. | User interface for diabetes management system |
AU2017207484B2 (en) | 2016-01-14 | 2021-05-13 | Bigfoot Biomedical, Inc. | Adjusting insulin delivery rates |
US10765807B2 (en) | 2016-09-23 | 2020-09-08 | Insulet Corporation | Fluid delivery device with sensor |
US11033682B2 (en) | 2017-01-13 | 2021-06-15 | Bigfoot Biomedical, Inc. | Insulin delivery methods, systems and devices |
EP3618713B1 (en) | 2017-05-05 | 2021-12-15 | Eli Lilly and Company | Closed loop control of physiological glucose |
WO2019125932A1 (en) | 2017-12-21 | 2019-06-27 | Eli Lilly And Company | Closed loop control of physiological glucose |
USD928199S1 (en) | 2018-04-02 | 2021-08-17 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
US11147919B2 (en) * | 2018-04-23 | 2021-10-19 | Medtronic Minimed, Inc. | Methodology to recommend and implement adjustments to a fluid infusion device of a medication delivery system |
JP7124120B2 (ja) | 2018-05-04 | 2022-08-23 | インスレット コーポレイション | 制御アルゴリズムベースの薬物送達システムのための安全制約 |
EP3856285A1 (en) | 2018-09-28 | 2021-08-04 | Insulet Corporation | Activity mode for artificial pancreas system |
WO2020077223A1 (en) | 2018-10-11 | 2020-04-16 | Insulet Corporation | Event detection for drug delivery system |
USD920343S1 (en) | 2019-01-09 | 2021-05-25 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
US11986629B2 (en) | 2019-06-11 | 2024-05-21 | Medtronic Minimed, Inc. | Personalized closed loop optimization systems and methods |
CN113950341B (zh) | 2019-05-20 | 2024-03-19 | 优诺医疗有限公司 | 可旋转的输注装置及其方法 |
DE112020003406T5 (de) | 2019-07-16 | 2022-06-23 | Beta Bionics, Inc. | Blutzuckerkontrollsystem |
JP2022541491A (ja) | 2019-07-16 | 2022-09-26 | ベータ バイオニクス,インコーポレイテッド | 血糖制御システム |
US11957876B2 (en) | 2019-07-16 | 2024-04-16 | Beta Bionics, Inc. | Glucose control system with automated backup therapy protocol generation |
US11801344B2 (en) | 2019-09-13 | 2023-10-31 | Insulet Corporation | Blood glucose rate of change modulation of meal and correction insulin bolus quantity |
US11213623B2 (en) * | 2019-09-20 | 2022-01-04 | Medtronic Minimed, Inc. | Infusion systems and related personalized bolusing methods |
US11935637B2 (en) | 2019-09-27 | 2024-03-19 | Insulet Corporation | Onboarding and total daily insulin adaptivity |
US11872033B2 (en) | 2019-11-15 | 2024-01-16 | Lifescan Ip Holdings, Llc | Methods and devices for visualizing analyte measurements |
US11654236B2 (en) * | 2019-11-22 | 2023-05-23 | Tandem Diabetes Care, Inc. | Systems and methods for automated insulin delivery for diabetes therapy |
US11957875B2 (en) | 2019-12-06 | 2024-04-16 | Insulet Corporation | Techniques and devices providing adaptivity and personalization in diabetes treatment |
US11833329B2 (en) | 2019-12-20 | 2023-12-05 | Insulet Corporation | Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns |
US11551802B2 (en) | 2020-02-11 | 2023-01-10 | Insulet Corporation | Early meal detection and calorie intake detection |
US11986630B2 (en) | 2020-02-12 | 2024-05-21 | Insulet Corporation | Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk |
US11547800B2 (en) | 2020-02-12 | 2023-01-10 | Insulet Corporation | User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system |
US11324889B2 (en) | 2020-02-14 | 2022-05-10 | Insulet Corporation | Compensation for missing readings from a glucose monitor in an automated insulin delivery system |
US20210283332A1 (en) * | 2020-03-10 | 2021-09-16 | Trustees Of Boston University | Integrated user-defined input into a closed-loop glucose control system |
US11607493B2 (en) * | 2020-04-06 | 2023-03-21 | Insulet Corporation | Initial total daily insulin setting for user onboarding |
CN111632228B (zh) * | 2020-05-19 | 2021-05-25 | 中国科学院深圳先进技术研究院 | 一种基于可穿戴监测方法的闭环人工胰腺系统 |
USD977502S1 (en) | 2020-06-09 | 2023-02-07 | Insulet Corporation | Display screen with graphical user interface |
CN114099846A (zh) * | 2020-08-26 | 2022-03-01 | 上海移宇科技股份有限公司 | 闭环人工胰腺胰岛素输注控制系统 |
US20230263430A1 (en) * | 2020-08-26 | 2023-08-24 | Medtrum Technologies Inc. | Closed-loop artificial pancreas insulin infusion control system |
EP4232119A1 (en) * | 2020-10-22 | 2023-08-30 | Insulet Corporation | Insulin pump for ensured site health and blood glucose control for aid systems |
US11904140B2 (en) | 2021-03-10 | 2024-02-20 | Insulet Corporation | Adaptable asymmetric medicament cost component in a control system for medicament delivery |
WO2022204705A1 (en) * | 2021-03-25 | 2022-09-29 | Beta Bionics, Inc. | Emergency medicament dose control |
US20220347386A1 (en) * | 2021-04-28 | 2022-11-03 | Insulet Corporation | Devices and methods for initialization of drug delivery devices using measured analyte sensor information |
US20220400985A1 (en) | 2021-06-18 | 2022-12-22 | Lifescan Ip Holdings, Llc | System And Method For Tracking And Presenting Glucose Monitor Data |
WO2023049900A1 (en) | 2021-09-27 | 2023-03-30 | Insulet Corporation | Techniques enabling adaptation of parameters in aid systems by user input |
US11439754B1 (en) | 2021-12-01 | 2022-09-13 | Insulet Corporation | Optimizing embedded formulations for drug delivery |
US20240009392A1 (en) * | 2022-07-11 | 2024-01-11 | Insulet Corporation | Informing a user of anticipated insulin delivery actions and providing recommended user actions |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140114278A1 (en) | 2007-10-09 | 2014-04-24 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
JP2014524294A (ja) | 2011-08-12 | 2014-09-22 | ジーン オニキス リミテッド | インスリンポンプ |
JP2015521902A (ja) | 2012-06-29 | 2015-08-03 | アニマス・コーポレイション | 閉ループコントローラのための手動ボーラス投与又は食事イベント管理方法及びシステム |
US20160038675A1 (en) | 2014-08-06 | 2016-02-11 | Bigfoot Biomedical, Inc. | Infusion pump assembly and method |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN661995A0 (en) | 1995-11-16 | 1995-12-07 | Memtec America Corporation | Electrochemical cell 2 |
US6444115B1 (en) | 2000-07-14 | 2002-09-03 | Lifescan, Inc. | Electrochemical method for measuring chemical reaction rates |
EP1575656B1 (en) | 2002-10-11 | 2009-06-17 | Becton, Dickinson and Company | Insulin delivery system with sensor |
US8060173B2 (en) | 2003-08-01 | 2011-11-15 | Dexcom, Inc. | System and methods for processing analyte sensor data |
ITBO20050002A1 (it) | 2005-01-04 | 2006-07-05 | Giacomo Vespasiani | Metodo e sistema per la gestione interattiva di dati relativi ad una terapia insulinica in autocontrollo per un paziente diabetico |
US8163162B2 (en) | 2006-03-31 | 2012-04-24 | Lifescan, Inc. | Methods and apparatus for analyzing a sample in the presence of interferents |
US20080269714A1 (en) * | 2007-04-25 | 2008-10-30 | Medtronic Minimed, Inc. | Closed loop/semi-closed loop therapy modification system |
US20080269723A1 (en) * | 2007-04-25 | 2008-10-30 | Medtronic Minimed, Inc. | Closed loop/semi-closed loop therapy modification system |
ES2785056T3 (es) * | 2007-07-02 | 2020-10-05 | Hoffmann La Roche | Un dispositivo para la administración de fármacos |
US20090177147A1 (en) | 2008-01-07 | 2009-07-09 | Michael Blomquist | Insulin pump with insulin therapy coaching |
WO2009095908A2 (en) | 2008-01-28 | 2009-08-06 | Medingo Ltd. | Bolus dose determination for a therapeutic fluid dispensing system |
GB2466183A (en) | 2008-12-09 | 2010-06-16 | Cambridge Entpr Ltd | Closed loop diabetes management system |
US8974439B2 (en) | 2009-01-02 | 2015-03-10 | Asante Solutions, Inc. | Infusion pump system and methods |
WO2010099313A1 (en) | 2009-02-25 | 2010-09-02 | University Of Virginia Patent Foundation | Cgm-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction insulin delivery |
EP2413781B1 (en) | 2009-03-31 | 2019-07-24 | Abbott Diabetes Care Inc. | Overnight closed-loop insulin delivery with model predictive control and glucose measurement error model |
EP2433235A2 (en) | 2009-05-22 | 2012-03-28 | Abbott Diabetes Care, Inc. | Safety features for integrated insulin delivery system |
US8762070B2 (en) | 2010-02-11 | 2014-06-24 | Regents Of The University Of California | Systems, devices and methods to deliver biological factors or drugs to a subject |
US20110313680A1 (en) | 2010-06-22 | 2011-12-22 | Doyle Iii Francis J | Health Monitoring System |
WO2012051344A2 (en) | 2010-10-12 | 2012-04-19 | Regents Of The University Of California, The | Maintaining multiple defined physiological zones using model predictive control |
US20130338629A1 (en) | 2012-06-07 | 2013-12-19 | Medtronic Minimed, Inc. | Diabetes therapy management system for recommending basal pattern adjustments |
US9526834B2 (en) | 2012-08-30 | 2016-12-27 | Medtronic Minimed, Inc. | Safeguarding measures for a closed-loop insulin infusion system |
US9171343B1 (en) * | 2012-09-11 | 2015-10-27 | Aseko, Inc. | Means and method for improved glycemic control for diabetic patients |
US9907909B2 (en) | 2012-12-20 | 2018-03-06 | Animas Corporation | Method and system for a hybrid control-to-target and control-to-range model predictive control of an artificial pancreas |
CN105050539B (zh) | 2013-01-14 | 2018-05-18 | 加利福尼亚大学董事会 | 用于1型糖尿病应用的人造胰腺的模型预测控制问题中的每日周期性目标区间调节 |
US9861747B2 (en) | 2013-12-05 | 2018-01-09 | Lifescan, Inc. | Method and system for management of diabetes with a glucose monitor and infusion pump to provide feedback on bolus dosing |
WO2015116524A1 (en) * | 2014-01-31 | 2015-08-06 | Trustees Of Boston University | Offline glucose control based on preceding periods |
ES2921199T3 (es) * | 2014-08-01 | 2022-08-19 | Becton Dickinson Co | Dispositivo de inyección con monitorización continua de glucosa |
-
2017
- 2017-04-18 US US15/489,773 patent/US11147920B2/en active Active
-
2018
- 2018-04-05 JP JP2019556661A patent/JP7153668B2/ja active Active
- 2018-04-05 BR BR112019021802A patent/BR112019021802A2/pt not_active IP Right Cessation
- 2018-04-05 AU AU2018255170A patent/AU2018255170A1/en not_active Abandoned
- 2018-04-05 CA CA3062078A patent/CA3062078A1/en active Pending
- 2018-04-05 KR KR1020197033959A patent/KR20190141704A/ko unknown
- 2018-04-05 WO PCT/US2018/026208 patent/WO2018194838A1/en unknown
- 2018-04-05 CN CN201880040585.6A patent/CN110913930B/zh active Active
- 2018-04-05 EP EP18788480.4A patent/EP3612255A4/en not_active Withdrawn
- 2018-04-05 RU RU2019136677A patent/RU2758210C2/ru active
- 2018-04-16 TW TW107112854A patent/TW201900229A/zh unknown
-
2021
- 2021-10-18 US US17/503,720 patent/US20220031950A1/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140114278A1 (en) | 2007-10-09 | 2014-04-24 | Dexcom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
JP2014524294A (ja) | 2011-08-12 | 2014-09-22 | ジーン オニキス リミテッド | インスリンポンプ |
JP2015521902A (ja) | 2012-06-29 | 2015-08-03 | アニマス・コーポレイション | 閉ループコントローラのための手動ボーラス投与又は食事イベント管理方法及びシステム |
US20160038675A1 (en) | 2014-08-06 | 2016-02-11 | Bigfoot Biomedical, Inc. | Infusion pump assembly and method |
Also Published As
Publication number | Publication date |
---|---|
EP3612255A1 (en) | 2020-02-26 |
JP2020518327A (ja) | 2020-06-25 |
AU2018255170A1 (en) | 2019-11-07 |
US20180296757A1 (en) | 2018-10-18 |
RU2019136677A (ru) | 2021-05-18 |
CN110913930B (zh) | 2022-10-14 |
US11147920B2 (en) | 2021-10-19 |
TW201900229A (zh) | 2019-01-01 |
CA3062078A1 (en) | 2018-10-25 |
RU2758210C2 (ru) | 2021-10-26 |
US20220031950A1 (en) | 2022-02-03 |
RU2019136677A3 (ja) | 2021-05-18 |
CN110913930A (zh) | 2020-03-24 |
WO2018194838A1 (en) | 2018-10-25 |
EP3612255A4 (en) | 2020-12-23 |
KR20190141704A (ko) | 2019-12-24 |
BR112019021802A2 (pt) | 2020-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7153668B2 (ja) | 自動基礎インスリン制御及び手動ボーラスインスリン制御を有する糖尿病管理システム | |
US20180043095A1 (en) | Method and system for closed-loop control of an artificial pancreas | |
CN111246899B (zh) | 具有用于自动的基础胰岛素输送操作的可配置目标血糖值的胰岛素输注设备 | |
TWI601547B (zh) | 用於閉路控制器之處置手動給藥或餐食事件之方法及系統 | |
TWI671094B (zh) | 用於控制人工胰臟中之封閉迴路控制器因感測器更換後之調諧因子的系統 | |
TWI619481B (zh) | 用於調諧人工胰臟之閉迴路控制器的方法及系統 | |
TW201503921A (zh) | 用於人工胰臟之混合式控制至目標及控制至範圍模型預測控制的方法及系統 | |
RU2752597C2 (ru) | Поддержание максимальных пределов дозирования для систем управления введением инсулина с обратной связью | |
TW201832788A (zh) | 使用於藥物遞送系統中之具有經改良安全性的音頻投藥 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20191211 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20191211 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210114 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210928 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210930 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211224 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220524 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220822 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20220913 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221003 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7153668 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |